Yu, Yangyiyi
Jin, Hui
Zhou, Shihang
Zhao, Ming
Wu, Haijing
Long, Hai
Fu, Siqi
Wu, Ruifang
Yin, Heng
Liao, Jieyue
Luo, Shuangyan
Liu, Yu
Zhang, Qing
Zhang, Peng
Tan, Yixin
Huang, Xin
Li, Fen
Lin, Guanghui
Lu, Qianjin http://orcid.org/0000-0002-7749-9618
Funding for this research was provided by:
National Natural Science Foundation of China (No.81830097)
Chinese Academy of Medical Sciences Initiative for Innovative Medicine (No.2021-I2M-1-059)
Special Funds for the Basic Research and Development Program in the Central Non-profit Research Institutesof China (2020-RC320-003)
Special Program of National Natural Science Foundation of China (32141004)
Innovative Research Group Project of the National Natural Science Foundation of China (81874253)
Ontario Ministry of Health and Long-Term Care (2022T150742)
Program for Top 100 Innovative Talents in Colleges and Universities of Hebei Province (2020RC2014)
Natural Science Foundation of Hunan Province China (2021JJ40837)
Article History
Received: 6 November 2022
Revised: 25 April 2023
Accepted: 1 June 2023
First Online: 13 June 2023
Declarations
:
: This study was registered with the Chinese Clinical Trial Registry (registration number: ChiCTR2100048939) and was approved by the Ethics Committee of The Second Xiangya Hospital of Central South University (LEMCSC_2013.11.05) and the ethics committees of participating institutions. This study has therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. All persons gave their informed consent prior to their inclusion in the study. Details that might disclose the identity of the subjects under study should be omitted.
: None.